IRLAB Publishes Interim Report for the Period January - March 2025

GOTHENBURG, SE / ACCESS Newswire / May 7, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company's interim report for the period …
Jetzt den vollständigen Artikel lesen